Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.
By Sonia Elijah
It recently came to my attention that communication within the U.S. Food and Drug Administration (FDA) evidences the Gold Standard agency’s explicit involvement in the Ivermectin disinformation war. While the agency approves ivermectin as an anti-parasite medicine, physicians have increasingly embraced it as an off-label treatment for early-onset COVID-19. Over 60 studies around the world have, for the most part, found positive findings; however, the mainstream media embraced the handful that are neutral or had data problems, for example. Regardless of position, a disinformation campaign was initiated by the FDA and others to deter the use of the off-label treatment. See the email here.
In my investigative report: How ivermectin became a target for the ‘fraud detectives,’ published in TrialSite, I highlighted the relentless smear campaign against this life-saving generic drug by a certain group of scientists/bloggers, which has been amplified in the mainstream media. My report included the overtly biased and controversial ‘You’re ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).